We are live on
!
Find out more
BTTX
Better Therapeutics, Inc. Common Stock
BTTX
BTTX
Delisted
BTTX was delisted on the 15th of March, 2024.
14 hedge funds and large institutions have $7.16M invested in Better Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% less funds holding
Funds holding: 20 → 14 (-6)
56% less capital invested
Capital invested by funds: $16.4M → $7.16M (-$9.27M)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
14
Holders Change
-6
Holders Change %
-30%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
7
Closed
9
Calls
$298K
Puts
–
Net Calls
+$298K
Net Calls Change
-$691K
Top Buyers
| 1 |
Norges Bank
Oslo,
Norway
|
+$2.06M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$943K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$279K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$120K |
| 5 |
Two Sigma Advisers
New York
|
+$43.2K |
